The announcement comes after company CFO recently told the Wall Street Journal that Hologic operates under a “philosophy that mass layoffs are a failure of leadership.”

Katie Hobbins, Managing Editor

March 29, 2024

1 Min Read
Hologic facility closures
StockSeller_ukr / iStock / Getty Images Plus via Getty Images

Hologic recently outlined changes in its quarterly Form 10-Q filed with the SEC, writing that it plans to close an unspecified number of international facilities within its diagnostic division amid product discontinuations and restructuring. In the regulatory filing, the company did not disclose how many employees will be affected by the shutdowns, but said it expects to incur about $4 million to $8 million in severance costs related to the actions. Additionally, the medtech company said it is in discussions with works councils — bodies that represent employees in many European countries — connected to its restructuring efforts.

Hologic also “recorded accelerated depreciation of $7.2 million and a lease asset impairment charge of $12.5 million” in its fiscal first quarter as a result of its strategy changes, according to the filing.

Like many companies who offer diagnostic products, Hologic has seen noted decreases in revenue since the COVID-19 pandemic waned. In the first quarter, the company reported its total diagnostic revenue was down 20%. However, company spokesperson Bridget Perry told Medtech Dive, who originally reported the story, that “The international activity is not connected to COVID revenue.”

Hologic wrote in the SEC filing that “This action is expected to be completed by the end of calendar 2024.”

The news of the international closures and possible layoffs come not long after Hologic CFO Karleen Oberton recently scolded executives enacting layoffs in the medtech industry, telling The Wall Street Journal that the company has avoided these actions by carefully managing its hiring. Additionally, Oberton told the journal that, even before the COVID-19 pandemic, Hologic operated under a “philosophy that mass layoffs are a failure of leadership.”

Hologic did not respond to MD+DI’s request for comment.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like